£20,000 in savings? Here’s how I’d aim to turn that into a £7,614 monthly second income!

Putting money into high-quality FTSE 100 and FTSE 250 shares can help investors unlock a life-changing second income over time.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Rear View Of Woman Holding Man Hand during travel in cappadocia

Image source: Getty Images

Charlie Munger famously said: “The first rule of compounding: Never interrupt it unnecessarily.” This tenet applies whether an investor has already built up a large second income or is still working towards one.

Therefore, it’s always a good idea to have some savings set aside for a rainy day. Back in the day, a rainy day would have made it difficult to work outdoors and earn income (hence the phrase).

Nowadays, it could be anything from a broken boiler to a poorly pet. The last thing an investor wants to do is sell stocks (potentially at a loss) to cover an unforeseen bill. So Cash ISAs definitely have a role to play.

But assuming this base is covered, I’d want the rest of my savings in a Stocks and Shares ISA over the long run. Here’s why.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Stairs and elevators

Put simply, stocks deliver better long-term returns than other asset classes, particularly cash.

This doesn’t mean they’re always a sure bet, mind. Reduced dividends, bear markets and crashes, and a myriad of other events (wars, pandemics, financial panics, etc.) do happen. Often unexpectedly.

That’s why the stock market tends to deliver superior returns over time. Investors want a higher potential rate of return for taking on all this extra risk. Otherwise, why bother putting oneself through the wringer?!

Also, as a general rule, stock markets take the stairs up and the elevator down. In other words, they rise steadily but can drop dramatically.

That’s why it’s important to take a long-term, Foolish approach to investing.

Of course, tuning out all the noise when things are going south isn’t easy. But it is possible to cultivate a patient mindset with enough experience.

Life-changing passive income

Long term, the blue-chip FTSE 100 has returned almost 8% a year on average, while the mid-cap FTSE 250 has delivered around 10.5%. Both figures are with dividends reinvested rather than spent.

If this record continues, a £20k lump sum equally invested across these indexes would turn into an eye-catching £304,406 over the next 30 years (excluding any ISA platform fees).

However, if I decided to invest a further £650 a month – the equivalent of £150 a week – along the way, my total would be transformed into a mighty £1,522,806. So, just over £1.5m!

From this, I could decide to take £91,368 a year in passive income from a 6%-yielding dividend portfolio. That’s the equivalent of a tax-free £7,614 monthly second income.

A world-class company

To achieve this, I’d build a portfolio with quality stocks like AstraZeneca (LSE: AZN).

There are a number of things I like here. For starters, the pharma giant has 12 blockbuster drugs (those generating $1bn in annual sales) as well as a gigantic pipeline of future potential wonder treatments.

Naturally, some won’t come to fruition, meaning clinical trial failures are an unavoidable risk. But I find Astra’s deep pipeline reassuring.

Second, the company remains extremely ambitious. It recently said it’s aiming to grow revenue by about 75% to $80bn by 2030.

This will be through the potential launch of 20 new medicines as well as growth in its existing oncology, biopharmaceuticals, and rare disease portfolio.

Given this possibility and the firm’s excellent recent record of execution, I find the stock’s forward price-to-earnings multiple of 18.7 attractive.

Ben McPoland has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

UK money in a Jar on a background
Investing Articles

A SIPP seems to offer investors free money – is there a catch?

This writer doesn't believe in magic money trees, but does see the offer of tax relief within a SIPP as…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

Here’s what £10,000 invested in Greggs shares a year ago’s worth now

Given Greggs large shop network and simple business formula, could owning the shares help this writer build wealth? Maybe --…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

Recent BT share price performance is jaw-dropping but can it continue?

Harvey Jones is stunned by how well the BT share price has weathered recent stock market volatility. Can the FTSE…

Read more »

A senior man using hiking poles, on a hike on a coastal path along the coastline of Cornwall.
Investing Articles

Is the stock market correction a once-in-a-decade chance to target a million-pound SIPP?

After recent volatility Harvey Jones can see plenty of value FTSE 100 stocks to help investors build wealth in a…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

How to target a £10k annual income from just one year’s £20,000 Stocks and Shares ISA allowance

Today is the start of the new financial year giving us all a a fresh Stocks and Shares ISA allowance.…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Rolls-Royce shares have gone nowhere this year. Is that a warning sign?

Rolls-Royce shares stand within spitting distance of where they began the year. Has the company's long run of strong share…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

£5,000 invested in Tesla stock on Christmas Eve is now worth…

Tesla stock is stuck in reverse at the moment. This year, it has fallen by around 15%. Is there potential…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

2 UK dividend stocks to consider buying in April

High-quality established businesses with reliable cash flows often make for great dividend stocks. Here are two for investors to take…

Read more »